주요 콘텐츠로 건너뛰기
번역 진행 중 — 귀하의 언어 버전을 준비하는 동안 이 콘텐츠가 영어로 표시됩니다.
토론으로 돌아가기

How can using advanced cancer models improve treatment options for patients with different types of cancer?

Healthcare
글로벌
August 09, 2026에 시작됨

Nature, Published online: 05 August 2026; doi:10.1038/s41586-026-10843-7 Integration of genome-scale CRISPR screening data from traditional cell lines and next-generation cancer models expands the representation of tumour subtypes and genomic alterations in The Cancer Dependency Map

출처 기사

진술 추가 분석 0/5
Need to find a specific claim? Search all statements.
🗳️ Join the conversation
10 투표할 진술 • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (10+ recommended) 10/10
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM 게시자: admin • Aug 09, 2026
The use of advanced cancer models should be prioritized in clinical trials to improve patient outcomes.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
💬 토론 보기
Be first to respond
Vote to see results
CLAIM 게시자: admin • Aug 09, 2026
Incorporating diverse cancer models will lead to significant advancements in treatment for rare cancer types.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
💬 토론 보기
Be first to respond
Vote to see results
CLAIM 게시자: admin • Aug 09, 2026
Whether researchers use organoids, patient-derived xenografts, or organ-on-chip systems, cancer models must represent the full diversity of genomic subtypes within each cancer type.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
💬 토론 보기
Be first to respond
Vote to see results
CLAIM 게시자: admin • Aug 09, 2026
Traditional 2D cell line screening has delivered most approved cancer drugs and should remain the foundation of drug discovery, with 3D models as secondary validation.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
💬 토론 보기
Be first to respond
Vote to see results
CLAIM 게시자: admin • Aug 09, 2026
Cancer research must integrate diverse tumour subtypes and genomic alterations into predictive models, regardless of which model platform proves most effective.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
💬 토론 보기
Be first to respond
Vote to see results
CLAIM 게시자: admin • Aug 09, 2026
Advanced cancer models will enable more personalized treatment options for patients across various cancer types.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
💬 토론 보기
Be first to respond
Vote to see results
CLAIM 게시자: admin • Aug 09, 2026
Integrating genome-scale CRISPR data with next-generation cancer models will enhance our understanding of tumor biology.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
💬 토론 보기
Be first to respond
Vote to see results
CLAIM 게시자: admin • Aug 09, 2026
Mandating next-generation models in drug development will delay life-saving treatments from reaching patients with rare cancers.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
💬 토론 보기
Be first to respond
Vote to see results
CLAIM 게시자: admin • Aug 09, 2026
Patient-derived cancer models raise serious ethical concerns about tissue ownership and informed consent that must be resolved before expansion.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
💬 토론 보기
Be first to respond
Vote to see results
CLAIM 게시자: admin • Aug 09, 2026
Funding for cancer research should prioritise mapping genomic dependencies across all 25+ cancer types over funding any single model technology.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
💬 토론 보기
Be first to respond
Vote to see results

💡 How This Works

  • • Add Statements: Post claims or questions (10-500 characters)
  • • Vote: Agree, Disagree, or Unsure on each statement
  • • Respond: Add detailed pro/con responses with evidence
  • • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us